Frier Levitt is pleased to share the latest edition of our Healthcare Newsletter, a comprehensive resource delivering critical insights into the ever-evolving landscape of healthcare law. We are committed to keeping you informed, and this edition is packed with vital updates and in-depth analysis to help you navigate the complex world of healthcare regulations.
In this edition, we cover recent attorney publications and webinars, including: 
- Supreme Court Overturns the Chevron Doctrine – Potential Impacts on Healthcare Providers and Pharmacies – Part 2: Frier Levitt attorneys examine the Court’s decision and implications for entities in the healthcare and life sciences space in an insightful article.
- Exploring Hospital and Physician Dynamics: A Primer on Medical Staff Adverse Actions: This 3-part webinar series is designed for physicians, in-house counsel, corporate leaders, attorneys, and regulatory investigators that deal with hospital and healthcare systems. This series offers valuable insights into adverse actions in healthcare settings.
Additionally, the newsletter highlights recent client triumphs as well as insightful industry features:
- Frier Levitt Secures a Landmark $22M+ Trial Victory Against Caremark Recovering 100% of DIR Fees, Interest, and Attorney Fees: Frier Levitt secured a landmark federal court judgment on behalf of New York Cancer & Blood Specialists (NYCBS), confirming an arbitration award against Caremark, sharply criticizing one of CVS Health’s most secretive programs.
- Frier Levitt Cited Three Times in House Committee Report on PBMs “The Role of Pharmacy Benefit Managers in Prescription Drug Markets”: The report highlights critical issues in the PBM industry, and this recognition underscores our commitment for transparency in the healthcare and life sciences industries.
We encourage you to explore the new edition of our Healthcare Newsletter, designed to keep you ahead of the curve and provide you with the tools necessary to succeed in the ever-changing healthcare environment.
